- About
-
Projects
-
Column 1
- Advancing Regulatory Science
- Animal Health & Veterinary Medicine
- Expanded Access
- FDA Patient Listening Sessions
-
Column 2
- Food & Nutrition
- Improving Access to FDA Information
- Research
- Substance Use Disorders
-
Column 1
- News and Events
- Expanded Access eRequest
Announcements
(February 6, 2026) The Reagan-Udall Foundation for the FDA (Foundation) has appointed Adrian F. Hernandez, MD, MHS, as Chair of its Board of Directors. Dr. Hernandez, who has served on the Board since 2019, is a cardiologist and the Vice Dean for…
The Reagan-Udall Foundation for the FDA will honor the Produce Safety Alliance, Critical Path Institute, and Loren A. Eng with its Innovations in Regulatory Science & Policy Awards on December 9, 2025.
The Reagan-Udall Foundation for the FDA (the Foundation) seeks nominations for its annual Innovations in Regulatory Science & Policy Awards.
Coverage
Moderator Michael McCaughan and Dr. Amy Abernethy kicked off the fireside chat by reflecting on the evolution of RWD, including prior efforts such as the Friends RWD Pilot 1.0 Project and the COVID-19 Evidence Accelerator led by Friends and the Reagan-…
The FDA Public Engagement Staff, along with the Reagan-Udall Foundation, hosted the virtual event that was moderated by Aviva Strategies. The listening session provided a direct connection between the agency and the PF community allowing for better…
A new report from the Reagan-Udall Foundation for the Food and Drug Administration (FDA) has distilled longstanding challenges in rare disease drug development into 20 specific recommendations, aiming to consolidate years of regulatory dialogue into an…